can you ever stop taking a glp 1 GLP-1 Drugs Until Watch This (Ozempic) GLP-1 Medications Infographic | Medidex

Bibcode:2021ChPap..75.6625A

Nirmala, M.A

Discussion and Review of Recent Literature In the case of our patient, it appears that she developed IIH due to the abrupt cessation of the GLP-1 receptor agonist prescribed to her with resultant rapid weight gain, with her BMI increasing from 29 to 34 in a little over a month

Pathophysiology of MASLD/MASH MASLD is characterized by excessive fat accumulation in the liver, with a spectrum ranging from simple steatosis to MASH and potentially cirrhosis (Figure 1)

The tirzepatide has substantially cleared, but the semaglutide has not yet reached full steady-state concentration